Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development

Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development

Saved in:

Bibliographic Details
Main Authors:	Negar Seyed, Tahereh Taheri, Farhat Afrin, Hamidreza Majidiani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Microbiology
Subjects:	Leishmania concomitant immunity vaccine drug repurposing drug non-responsiveness infectious models
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1554339/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy
by: Al Samra Lynn, et al.
Published: (2025-01-01)

Immunogenicity and potential protection of DNA vaccine of Leishmania martiniquensis against Leishmania infection in mice
by: Thuntawat Aunguldee, et al.
Published: (2021-09-01)

Development of a novel ddPCR assay for the simultaneous detection of the protozoan parasites Leishmania infantum and Leishmania tarentolae
by: Alessandro Alvaro, et al.
Published: (2025-07-01)

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter
by: Teresa Pacifico, et al.
Published: (2025-07-01)

A one-step multiplex qPCR assay for simultaneous identification and quantification of Leishmania martiniquensis and Leishmania orientalis/Leishmania chancei and detection and quantification of trypanosomatids in clinical samples
by: Mano Chonlada, et al.
Published: (2025-01-01)

Effect of Leishmania proteins in mice: Investigation of Leishmania amazonensis virulence molecules for therapy and prophylaxis of leishmaniasis
by: Cintia Figueiredo de Araújo, et al.
Published: (2025-03-01)

In Silico Study of FDA-Approved Drugs on <i>Leishmania infantum</i> CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
by: Juan Diego Guarimata, et al.
Published: (2024-11-01)

Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant <i>Leishmania</i>
by: Sehyeon (Erica) Kim, et al.
Published: (2024-11-01)

Editorial: Benefit and risk on drug-drug interactions in infections
by: Hideo Kato, et al.
Published: (2025-04-01)

A new method for concomitant evaluation of drug combinations for their antimicrobial properties
by: Syed Ahmed Rizvi, et al.
Published: (2025-06-01)

Ascorbate peroxidase modulation confirms key role in Leishmania infantum oxidative defence
by: Isabella Fernandes Martins Santos, et al.
Published: (2024-11-01)

Drug Repurposing for Rare Orphan Diseases Using Machine Learning Techniques
by: Rajesh Manicavasaga, et al.
Published: (2022-05-01)

Pseudohypoxia-Stabilized HIF2α Transcriptionally Inhibits <i>MNRR1</i>, a Druggable Target in MELAS
by: Neeraja Purandare, et al.
Published: (2025-07-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

The efficacy of new 2,5-dihydroxybenzyl derivatives against Trypanosoma cruzi, Leishmania infantum and Leishmania braziliensis
by: Miriam Rolón, et al.
Published: (2019-06-01)

IMMUNE RESPONSE OF BALB/C MICE AGAINST GENETIC VACCINATION WITH LEISHMANIA MAJOR GP63 GENE (LMAJGP63)
by: Selman A. Ali, et al.
Published: (2016-06-01)

First molecular evidence of Leishmania parasites in sand flies (Diptera: Phlebotominae) from Slovenia
by: Gioia Bongiorno, et al.
Published: (2025-08-01)

Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani
by: Supratim Pradhan, et al.
Published: (2025-05-01)

Synthesis and Structure–Activity Relationship of Thiourea Derivatives Against <i>Leishmania amazonensis</i>
by: Gil Mendes Viana, et al.
Published: (2024-11-01)

In vitro activity of Curcuma longa Extract Against the Promastigote Stage of Cutaneous Leishmania Parasite
by: Faleeha Habeeb Hussien, et al.
Published: (2025-04-01)

Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01)

Efficacy of LaAg Vaccine Associated with Saponin Against <i>Leishmania amazonensis</i> Infection
by: Mirian França de Mello, et al.
Published: (2025-01-01)

Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design
by: Lisa Daniel-Fischer, et al.
Published: (2024-02-01)

Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content
by: Emerenziana Ottaviano, et al.
Published: (2025-05-01)

First report of Leishmania RNA virus 2 and its high genetic diversity in cutaneous leishmaniasis cases from Ilam Province, Iran
by: Reza Saberi, et al.
Published: (2025-08-01)

DNA Methylation in macrophages infected with Leishmania spp. in different culture conditions
by: Eleonora Loi, et al.
Published: (2025-12-01)

Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine
by: Douglas O. Ochora, et al.
Published: (2025-06-01)

Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
by: Zixun Wang, et al.
Published: (2025-03-01)

EXPLORING THE ROLE OF DRUGBANK IN INVESTIGATING PHARMACOGENOMIC-DRIVEN NOVEL DRUG
by: Setiyo Budi Santoso, et al.
Published: (2025-07-01)

Modulation of fibroblast behavior by Leishmania: a pathway to understanding disease progression in cutaneous leishmaniasis
by: Tarcisio Navegante de Queiroz Filho, et al.
Published: (2025-08-01)

Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities
by: Jieyi Di, et al.
Published: (2019-10-01)

IN SILICO AND IN VITRO ACTIVITY OF FRIEDELIN N-DERIVATIVES AGAINST PROMASTIGOTE FORMS OF Leishmania amazonensis
by: Mauro Lúcio Gonçalves de Oliveira, et al.
Published: (2025-08-01)

Results of a clinical study of Traumeel® S and Zeel® T in patients with knee osteoarthritis and concomitant cardiovascular disease
by: L. I. Alekseeva, et al.
Published: (2023-10-01)

CRYOPRESERVATION OF LEISHMANIA DONOVANI PROMASTIGOTES AT -80°C
by: E. Kaneva
Published: (2022-12-01)

A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules
by: Tejaswini Masne, et al.
Published: (2024-09-01)

Etiology of Infectious Complications and Antibiotic-Resistance of Major Causative Agents in Victims with Severe Injury
by: T. A. Vasina, et al.
Published: (2007-12-01)

Risk of End-Stage Kidney Disease and Topiramate Use
by: Jean-Michel Halimi, et al.
Published: (2025-08-01)

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation
by: Chawalit Ngernsombat, et al.
Published: (2024-12-01)

AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure
by: Ziad Sabry, et al.
Published: (2025-06-01)

Repurposing hydrochlorothiazide (HCTZ) for colorectal cancer: a retrospective and single center study
by: Dominic Chi-Chung Foo, et al.
Published: (2025-02-01)